ENTX

Entera Bio (ENTX)

Entera Bio Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ENTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	21:00	GlobeNewswire Inc.	Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member	NASDAQ:ENTX	Entera Bio Ltd
2024/05/13	20:00	GlobeNewswire Inc.	Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024	NASDAQ:ENTX	Entera Bio Ltd
2024/05/11	05:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ENTX	Entera Bio Ltd
2024/05/11	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENTX	Entera Bio Ltd
2024/05/11	05:10	GlobeNewswire Inc.	Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates	NASDAQ:ENTX	Entera Bio Ltd
2024/04/08	21:30	GlobeNewswire Inc.	Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research	NASDAQ:ENTX	Entera Bio Ltd
2024/03/26	21:30	GlobeNewswire Inc.	Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months	NASDAQ:ENTX	Entera Bio Ltd
2024/03/20	21:00	GlobeNewswire Inc.	Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	NASDAQ:ENTX	Entera Bio Ltd
2024/03/09	06:25	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ENTX	Entera Bio Ltd
2024/03/09	06:12	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ENTX	Entera Bio Ltd
2024/03/09	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENTX	Entera Bio Ltd
2024/03/09	06:05	GlobeNewswire Inc.	Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates	NASDAQ:ENTX	Entera Bio Ltd
2024/03/04	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENTX	Entera Bio Ltd
2024/03/04	22:30	GlobeNewswire Inc.	Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:ENTX	Entera Bio Ltd
2024/02/16	07:10	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ENTX	Entera Bio Ltd
2024/02/15	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ENTX	Entera Bio Ltd
2024/02/14	20:05	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:ENTX	Entera Bio Ltd
2024/02/03	06:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENTX	Entera Bio Ltd
2024/02/03	06:17	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ENTX	Entera Bio Ltd
2024/01/30	22:30	GlobeNewswire Inc.	Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:ENTX	Entera Bio Ltd
2024/01/16	22:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENTX	Entera Bio Ltd
2024/01/12	08:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENTX	Entera Bio Ltd
2024/01/04	08:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENTX	Entera Bio Ltd
2024/01/04	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENTX	Entera Bio Ltd
2024/01/04	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENTX	Entera Bio Ltd
2024/01/04	06:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENTX	Entera Bio Ltd
2024/01/03	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENTX	Entera Bio Ltd
2024/01/03	07:19	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ENTX	Entera Bio Ltd
2023/12/27	22:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ENTX	Entera Bio Ltd
2023/12/26	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENTX	Entera Bio Ltd